Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines
Desikan, R.; Linderman, S. L.; Davis, C. W.; Zarnitsyna, V. I.; Ahmed, H. R.; Antia, R.
Show abstract
When should vaccines to evolving pathogens such as SARS-CoV-2 be updated? Our computational models address this focusing on updating SARS-CoV-2 vaccines to the currently circulating Omicron variant. Current studies typically compare the antibody titers to the new variant following a single dose of the original-vaccine versus the updated-vaccine in previously immunized individuals. These studies find that the updated-vaccine does not induce higher titers to the vaccine-variant compared with the original-vaccine, suggesting that updating may not be needed. Our models recapitulate this observation but suggest that vaccination with the updated-vaccine generates qualitatively different humoral immunity, a small fraction of which is specific for unique epitopes to the new variant. Our simulations suggest that these new variant-specific responses could dominate following subsequent vaccination or infection with either the currently circulating or future variants. We suggest a two-dose strategy for determining if the vaccine needs updating and for vaccinating high-risk individuals.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Asynchrony between virus diversity and antibody selection limits influenza virus evolution 94%
- Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants 94%
- Dynamically Linking Influenza Virus Infection Kinetics, Lung Injury, Inflammation, and Disease Severity 94%
Similar papers in this journal
- Computing the inducibility of B cell lineages under a context-dependent model of affinity maturation: Applications to sequential vaccine design 93%
- Rate of immune complex cycling in follicular dendritic cell determines the extent of protecting antigen integrity and availability to germinal center B cells 91%
- The pre-existing human antibody repertoire to computationally optimized influenza H1 hemagglutinin vaccines 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.